Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
Ontology highlight
ABSTRACT: To analyze the pathological tumor response on resected colorectal cancer metastases after preoperative treatment with cetuximab combined with FOLFOX or FOLFIRI regimen in a prospective cohort (RAS and B-RAF WT tumors) and to correlate this response with patient’s outcome.
DISEASE(S): Metastatic Colorectal Cancer,Potentialy Or Borderline Resecable Metastatic Colorectal Cancer(ras And B-raf W-t) At Diagnosis And For Whom A Multidisciplinary Meeting Recommended Chemotherapy First In A Curative Intent.,Colorectal Neoplasms
PROVIDER: 2145197 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA